Skip to content

Drug interactions

Apixaban + Efavirenz

Severity: Moderate

Apixaban and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may lower apixaban exposure because apixaban is partly cleared through CYP3A4 and P-gp. Reduced anticoagulant effect could increase the risk of thromboembolism.

What this interaction means in plain words

Apixaban and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apixaban belongs to Cardiovascular; Efavirenz belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Efavirenz induction of CYP3A4 and P-glycoprotein increases apixaban clearance.

What to do

Monitor for thrombotic events and consider an alternative anticoagulant when a stable effect is critical. Apixaban labeling advises avoiding combined strong dual inducers where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apixaban and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apixaban with Efavirenz?

MediHelp rates the interaction as moderate. Apixaban and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz may lower apixaban exposure because apixaban is partly cleared through CYP3A4 and P-gp. Reduced anticoagulant effect could increase the risk of thromboembolism.

How serious is the interaction between Apixaban and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for thrombotic events and consider an alternative anticoagulant when a stable effect is critical. Apixaban labeling advises avoiding combined strong dual inducers where possible.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in